Search results

Page results

• Study highlights chronic nature of obesity and need for ongoing treatment

  People with obesity whose weight and health improve following drug treatment are likely to need the treatment long term, according to a UCLH and UCL study.

• Covid-19 NHS vaccination centre opens at Francis Crick Institute

  UCLH and The Francis Crick Institute have formed a partnership to deliver a new large-scale COVID-19 vaccination centre at the Institute.

• Dr Satyen Gohil

  Dr Satyen Gohil specialises in treating patients with CLL and lymphoma and leads a number of clinical trials for these conditions.

• Secretary of State visits UCLH vaccination centre at Bidborough House

  The Secretary of State for Health and Social Care Sajid Javid visited the UCLH vaccination centre at UCL’s Bidborough House on Thursday 23 September to see the vital role UCLH and UCL are playing in getting the UK’s population vaccinated for COVID-19.

• British Library collaborates with UCLH and The Crick to increase COVID-19 testing

  NHS and social care staff can now be swabbed for COVID-19 at a drive-through facility based at the British Library’s St Pancras site.

• Groundbreaking radiotherapy trial for UK brain cancer patients

  A cancer treatment that is currently available to only a limited number of UK patients is to be tested at UCLH in a countrywide clinical trial to see if it causes fewer long-term side effects than standard radiotherapy.

• Professor Bryan Williams elected President of the International Society of Hypertension

  UCLH Director of Research Professor Bryan Williams has been elected as the next President of the International Society of Hypertension (ISH).

• Getting Ready for Transition to Secondary School (GReaT)

  Getting Ready for Transition to Secondary School (GReaT) event for parents of children with type 1 diabetes

• New Charity Matters out now

  The autumn/winter edition of Charity Matters is out now.

• $175.5 million for immunotherapy spin-out to develop new treatments

  Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.